Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogenic bone marrow transplantation].

A Vítek1

  • 1Ustav hematologie a krevní transfuze, Praha. antonin.vitek@uhkt.cz

Casopis Lekaru Ceskych
|January 30, 2004
PubMed
Summary

Allogeneic bone marrow transplantation (alloBMT) offers a curative strategy for hematological diseases. The graft-versus-leukemia (GVL) effect from transplanted lymphocytes is crucial for its success, especially in non-myeloablative settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.

Bone marrow transplantation·2017
Same author

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.

Bone marrow transplantation·2017
Same author

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2017
Same author

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2016
Same author

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.

Bone marrow transplantation·2016
Same author

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.

Annals of hematology·2016

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Context:

  • Allogeneic bone marrow transplantation (alloBMT) is a critical treatment for various hematological malignancies and non-malignant disorders.
  • For certain conditions, alloBMT is the sole curative option, while for others, it enhances outcomes in high-risk cases.

Purpose:

  • To explore the therapeutic mechanisms of alloBMT, focusing on the graft-versus-leukemia (GVL) effect.
  • To investigate the role of GVL in non-myeloablative transplantations (minitransplantations).

Summary:

  • The efficacy of alloBMT stems from both pre-transplantation cytostatic treatments and the GVL effect mediated by donor lymphocytes.
  • GVL is recognized as a highly effective anti-leukemia mechanism, driving research into its application in less intensive transplantation protocols.

Impact:

  • Understanding the GVL effect can optimize alloBMT strategies for improved patient outcomes in hematological diseases.
  • This research supports the development of refined transplantation techniques, potentially expanding treatment options for patients with limited alternatives.

Related Experiment Videos